Join the CRM Legacy Meeting for a comprehensive examination of Cardio-Renal-Metabolic health, focusing on the Empagliflozin-Linagliptin combination. Our expert panel will delve into the latest clinical evidence, exploring the benefits and applications of this dual therapy approach. This insightful session will provide actionable strategies for optimizing CRM patient outcomes, making it an essential event for healthcare professionals seeking to enhance their CRM practice.

CRM Legacy Meeting Unlocking Cardio-Renal-Metabolic Health: A Webinar on Empagliflozin-Linagliptin Combination

Consultant Diabetologist & Nephrologist, Varanasi

Dr. Prof K K Tripathi

2

434

7k

4.7

Sessions Taken

462

4.7

228

4.6